IL6 and COVID-19: Additionally, low expression of human leukocyte antigen-DR (HLA-DR) on CD14 monocytes were detected in COVID-19 patients inversely correlating with a high circulating level of IL-6 (56), suggesting a sepsis-induced immunoparalysis.